Who founded Waypoint Orthopedics?

Waypoint Orthopedics was founded by Dr. Stephen Banco M.D. in 2020.

How much funding has Waypoint Orthopedics raised?

Waypoint Orthopedics has disclosed $3.8M raised across 9 of its 10 known rounds.

Where is Waypoint Orthopedics headquartered?

Waypoint Orthopedics is headquartered in Malvern, US.

Waypoint Orthopedics

Malvern, US · Founded 2020 · Delaware corporation · 2 known investors

Find your way into Waypoint Orthopedics

Each arrow is one introduction. Sign up to fill in the first one.

140 people can intro you to William

Ask Ivy Zhang to introduce you to William S. Rhoda

You →Ivy · together at Seaspine →William

81 people can intro you to Jeffrey

Ask Jamie Chen to introduce you to Jeffrey O'Donnell, Jr.

You →Jamie · together at Intact Vascular →Jeffrey

57 people can intro you to Jeffrey

Ask Sam Okafor to introduce you to Jeffrey O'Donnell Sr.

You →Sam · together at BioStar Ventures →Jeffrey

Your email: who you already know at Waypoint Orthopedics, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Waypoint Orthopedics team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Waypoint Orthopedics develops GPS (Guided Pedicle System), a vertebral fixation device that gives spine surgeons real-time guidance to improve accuracy and reduce radiation exposure during open and minimally invasive spine surgery. The FDA-cleared system is aimed at spine surgeons, surgical staff, and patients in the medical device/orthopedics field.

Hardware Healthtech Medical Devices

Founders & leadership

Waypoint Orthopedics was founded in 2020 by Dr. Stephen Banco M.D..

Dr. Stephen Banco M.D.CMO / Co-founder

Stephen P. BancoExecutive

Jeffrey O'Donnell, Jr.President, Chief Executive Officer, and Board MemberJeffrey O'Donnell Jr. is an operating executive with over 15 years of experience in medical device development, having led multiple musculoskeletal and cardiovascular platforms through FDA clearance and commercialization; he serves as Chief Operating Officer and CEO of Runway Healthcare portfolio companies, including Waypoint Orthopedics, and is a General Partner at Runway Healthcare and MAST Labs, and holds a degree from the Haub School of Business at Saint Joseph's University.

William OdenthalExecutive

Jeffrey F. O'Donnell, Sr.ExecutiveJeffrey O'Donnell brings over 25 years of executive and board leadership experience in medical device companies, including founding and serving as CEO of Trice Medical (retired 2020), Embrella Cardiovascular (sold to Edwards Lifesciences in 2011), and Cardiovascular Dynamics (taken public on NASDAQ in 1996). He previously held CEO roles at PhotoMedex and Kensey Nash Corporation, and held senior sales and marketing positions at Boston Scientific, Guidant, and Johnson & Johnson's Orthopedic Division.

Jeff O'Donnell Jr.President & CEO

William S. Rhoda Chief Technology OfficerWilliam S. Rhoda co-founded and served as Vice President of Product Development at Globus Medical, and has held executive roles including President and CEO of OT Medical and General Manager of Process Innovation at SeaSpine; he is currently a General Partner and Chief Technology Officer at Runway Healthcare, a MedTech venture studio.

Tiffini WittwerHead of Quality and Regulatory Affairs

Jeffrey O'Donnell Sr.Executive ChairmanJeffrey O'Donnell Sr. has over 25 years of experience leading medical device companies, including roles as CEO of PhotoMedex, Cardiovascular Dynamics, and Trice Medical; he also founded Embrella Cardiovascular, which was acquired by Edwards Lifesciences in 2011. He holds a degree from LaSalle University and currently serves as Executive Chairman of Waypoint Orthopedics.

Board

Andrew LottBoard director

Investors · 2

Also in the syndicate · 2

Alere Financial PartnersRunway Healthcare, LPlead

Reported raises · per SEC filings

Form D private placements

$3.8M disclosed across 9 of 10 rounds · 2020–2026

▶$300KraisedMar 2026 · 8 investors · Other Health Care

Rule 506(b)